Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$161K Hold
275
﹤0.01% 499
2023
Q3
$143K Hold
275
﹤0.01% 491
2023
Q2
$149K Sell
275
-30
-10% -$16.4K ﹤0.01% 489
2023
Q1
$164K Hold
305
﹤0.01% 402
2022
Q4
$156K Hold
305
﹤0.01% 415
2022
Q3
$133K Hold
305
﹤0.01% 423
2022
Q2
$143K Hold
305
﹤0.01% 412
2022
Q1
$154K Buy
+305
New +$146K ﹤0.01% 418
2021
Q4
Sell
-305
Closed -$142K 482
2021
Q3
$142K Hold
305
﹤0.01% 365
2021
Q2
$145K Hold
305
﹤0.01% 355
2021
Q1
$140K Hold
305
﹤0.01% 361
2020
Q4
$162K Buy
+305
New +$150K ﹤0.01% 347

Other funds holding CHE

Bartlett & Co's CHE Position: Q4 2023 in Review

Bartlett & Co held its Chemed (CHE) position steady in Q4 2023 at 275 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Bartlett & Co first reported a position in CHE in Q4 2020 and has held it in 12 quarters since. The position peaked at $164K in Q1 2023. 500 funds tracked by Wall St. Rank hold CHE as of Q4 2023.

  • Bartlett & Co held 275 shares of Chemed worth $161K as of Q4 2023.
  • Bartlett & Co left its Chemed share count unchanged in Q4 2023.
  • Chemed made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #499 holding.
  • Bartlett & Co first reported a position in Chemed in Q4 2020 and has held it in 12 quarters since.
  • Bartlett & Co's Chemed position peaked at $164K in Q1 2023.
  • 500 funds tracked by Wall St. Rank held Chemed as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.